The Ofev Patent Thicket: Patents expiring in 2026
With an average life expectancy of 3-5 years after diagnosis, Pulmonary fibrosis highlights an urgent need for innovative therapeutic interventions. That’s where medications like Ofev have [...]
With an average life expectancy of 3-5 years after diagnosis, Pulmonary fibrosis highlights an urgent need for innovative therapeutic interventions. That’s where medications like Ofev have [...]
Trajenta, known for its effective glycemic control without weight gain, is a key player in the diabetes medication sector. This critical medication, known generically as Linagliptin, is on the [...]
The European Patent Office (EPO) receives more than 2000 oppositions each year, directly impacting the future success and exclusivity of pharmaceutical products. Monitoring the outcomes of these [...]
While numerous drugs for diabetes are available in the market, many come with undesirable side effects such as weight gain, hypoglycemia, and hypertension. However, a game-changing solution has [...]
The arthritis treatment industry is characterized by its intense competitiveness, driving companies to invest significantly in research and development to secure leading arthritis drug patents. [...]
More than 500 million people around the world are affected by diabetes, and this issue is intensified by a surging obesity crisis, particularly in wealthier nations. In such a crisis, drugs like [...]
The fiercely competitive nature of the oncology industry makes the companies invest heavily in research and development to bring in top cancer-treating drug patents. Consequently, the expiration [...]
Given the competitive nature of the pharmaceutical domain, the expiration of drug patents presents significant opportunities, particularly for companies specializing in generic medications. [...]
The recent FDA controversy around Novo Nordisk’s Ozempic has brought many eyes to the drug. For the uninitiated, Ozempic (semaglutide) is an anti-obesity medication for long-term weight [...]
Closely monitoring the patent expirations of well-known branded drugs, such as Abilify for schizophrenia and Abaraxane for cancer treatment, is essential. This practice of monitoring [...]
In 2020, the FDA approved loteprednol etabonate ophthalmic suspension 0.25% (Eysuvis, Kala Pharmaceuticals Inc.) for treating dry eye disease. As one of the most common ocular surface disorders, [...]
Monitoring the drug exclusivity expiration timelines is just as important as patent expiration date when identifying opportunities and timing generic launches. Having access to detailed [...]
During the second quarter of 2023, there was a 7% increase in patent applications for immuno-oncology compared to the previous quarter, indicating a dynamic transformation in the oncology [...]
With companies filing for ANDAs, the global prescribed generics sales are expected to reach nearly 100 billion U.S. dollars by 2026. One example of this is Rexulti – a prescription [...]
Are you familiar with Humira? The first fully lab-made immune protein approved by the US Food and Drug Administration (FDA) for various treatments. In case you aren’t, Humira is a [...]
If Drug research and development is your bread and butter, you must be familiar with the wonders of Stelara. For the uninitiated, Stelara is the brand name of the drug Ustekinumab, which is [...]
With the explosive growth in the generic drug market, generic companies (like yours) are in a battle to claim a share of the soon-to-be-expired drugs as quickly as possible. You would want to [...]
Conclusion Earlier we released a list of 91 drug patents expiring between 2020 to 2022. And while small molecule drugs still dominate the global pharmaceutical market in terms of numbers, many of [...]
Knowing the expiration date of a patent is important for multiple reasons; A key reason being that an expired patent goes into the public domain, which means everyone can now freely practice it. [...]
The Generic drugs industry is one of the fastest-growing industries of this century. Valued at USD 200 Billion in 2015, the global market for generic drugs is expected to reach USD 380 Billion by [...]
While much has been said about the need for a regular Competitor Patent Monitoring exercise in every major industry, the importance of the patent monitoring process in the Pharmaceutical [...]
Macitentan is a drug by Actelion for treating Pulmonary Arterial Hypertension (PAH). It’s popularly known as Opsumit and delays the progression of PAH, which got approval from the FDA in Dec [...]